The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants

The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants

Weimin Li,1 Sami Z Daoud,2 Roopa Trivedi,3 Pradeep B Lukka,4 Eulalia Jimenez,5 Eduard Molins,5 Catherine Stewart,6 Pranob Bharali,3,7 Esther Garcia-Gil8 1Clinical Trial Center, West China Hospital of Sichuan University, Chengdu, Sichuan Province, People’s Republic of China; 2Respiratory & Immuno...

Full description

Bibliographic Details
Main Authors:	Li W, Daoud SZ, Trivedi R, Lukka PB, Jimenez E, Molins E, Stewart C, Bharali P, Garcia-Gil E
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-11-01
Series:	International Journal of COPD
Subjects:	aclidinium bromide bronchodilator china chronic obstructive pulmonary disease pharmacokinetics safety.
Online Access:	https://www.dovepress.com/the-pharmacokinetics-safety-and-tolerability-of-aclidinium-bromide-400-peer-reviewed-fulltext-article-COPD

Similar Items

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
by: Sethi S, et al.
Published: (2019-03-01)

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
by: D'Urzo AD, et al.
Published: (2019-02-01)

The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial
by: Wise RA, et al.
Published: (2021-03-01)

12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review
by: A. A. Vizel, et al.
Published: (2018-10-01)

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD
by: Watz H, et al.
Published: (2017-08-01)

Effects of aclidinium on determinants of COPD severity: symptoms and quality of life
by: Contoli M, et al.
Published: (2016-12-01)

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
by: Matera MG, et al.
Published: (2016-01-01)

The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
by: Miravitlles M, et al.
Published: (2016-08-01)

New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease
by: S N Avdeev, et al.
Published: (2019-03-01)

A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study
by: Kostikas K, et al.
Published: (2020-03-01)

Cost versus utility of aclidinium bromide 400 μg plus formoterol fumarate dihydrate 12 μg compared to aclidinium bromide 400 μg alone in the management of moderate-to-severe COPD
by: Ramos M, et al.
Published: (2016-09-01)

A Real-World Study on the Day and Night-Time Symptoms Among Greek COPD Patients Who Recently Initiated Treatment with Dual Bronchodilation: The DANICO Study
by: Kostikas K, et al.
Published: (2022-09-01)

Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
by: Jones PW
Published: (2015-03-01)

Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study
by: Beier J, et al.
Published: (2017-06-01)

Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
by: Dave Singh, et al.
Published: (2017-05-01)

Bromomethane (methyl bromide)
by: 8096 British Standards Institution

The value of the medicine fenoterol + ipratropium bromide in the treatment of exacerbations of bronchial asthma and chronic obstructive pulmonary disease
by: О. A. Tsvetkova, et al.
Published: (2020-11-01)

Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists
by: Rebordosa C, et al.
Published: (2022-08-01)

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study
by: Jutta Beier, et al.
Published: (2013-08-01)

Modern possibilities of correction of broncho-obstructive syndrome in chronic heart failure of ischemic origin in combination with chronic obstructive pulmonary disease: simple randomized parallel group study
by: Vladimir V. Evdokimov, et al.
Published: (2023-06-01)

Photographic grade potassium bromide
by: 8096 British Standards Institution
Published: (1978)

NEW FIXED COMBINATION OF LONG-ACTING ANTICHOLINERGIC GLYCOPYRRONIUM BROMIDE AND β2-AGONIST OF INDACATEROL: PROSPECTS OF COBD THERAPY
by: S. N. AVDEEV
Published: (2016-12-01)

Comparative evaluation of valethamate bromide and hyoscine butyl bromide on cervical dilatation in water buffaloes after detorsion
by: RISHIPAL YADAV, et al.
Published: (2023-04-01)

Metilnaltreksonijev bromid
by: Jožica Červek
Published: (2008-12-01)

Synthesis of Triethyl Propargyl Ammonium Bromide from Triethyl Amine With Propargyl Bromide
by: Mohsen Ghalamkar Moazzam,, et al.
Published: (1990-06-01)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
by: Tashkin DP, et al.
Published: (2018-06-01)

Bronchodilator treatment of stable COPD: long-acting anticholinergics
by: W. Vincken
Published: (2005-09-01)

DIFFERENTIATED APPROACH TO THE APPOINTMENT OF BRONCHODILATOR THERAPY IN PATIENTS WITH COPD. EXAMPLES FROM PRACTICE
by: G. L. Ignatova, et al.
Published: (2017-11-01)

Is it possible to modify the course of chronic obstructive pulmonary disease with modern medication?
by: S N Avdeev
Published: (2008-08-01)

An update on the efficacy and safety of aclidinium bromide in patients with COPD
by: Khuder Alagha, et al.
Published: (2011-02-01)

About samarium bromide - carbamide complexes
by: Yu. L. Alikberova, et al.
Published: (2012-02-01)

Facile methylthiomethylation of the carboxylic acid with bromodimethylsulfonium bromide
by: Bo Dong, et al.
Published: (2022-08-01)

Bronchodilator Response in Patients with Persistent Allergic Asthma Could Not Predict Airway Hyperresponsiveness
by: Petanjek Bojana B, et al.
Published: (2007-12-01)

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease
by: Sims MW, et al.
Published: (2011-09-01)

Comparison of Ipratropium Bromide and Beclomethasone in conservative therapy of asthma
by: Kh Bijani, et al.
Published: (2001-07-01)

Leaching Chalcopyrite with an Imidazolium-Based Ionic Liquid and Bromide
by: Marcelo Rodríguez, et al.
Published: (2020-01-01)

Acetamide complexes of samarium chloride and bromide
by: L. Yu. Alikberova, et al.
Published: (2013-04-01)

Efficiency of tiotropium bromide in patients with severe persistent bronchial asthma in clinical practice
by: A. F. Ivanov, et al.
Published: (2018-04-01)

ANAPHYLACTIC SHOCK TO PANCURONIUM BROMIDE UNDER GENERAL ANESTHESIA: A CASE REPORT
by: K. Ghazi-Saidi
Published: (1998-08-01)

ANAPHYLACTIC SHOCK TO PANCURONIUM BROMIDE UNDER GENERAL ANESTHESIA: A CASE REPORT
by: K. Ghazi-Saidi
Published: (1998-12-01)